Related Experiment Video
Updated: Jun 1, 2026
05:24
Preparation of Mechanically Stable Self-Assembled Peptides Hydrogels
Published on: September 6, 2024
Drug release from hydrazone-containing peptide amphiphiles
John B Matson1, Samuel I Stupp
1Institute for BioNanotechnology in Medicine, Northwestern University, Chicago, IL 60611, USA.
Chemical Communications (Cambridge, England)
|June 16, 2011
Summary
Novel hydrazone tethers in peptide amphiphiles enable controlled drug release. This study precisely incorporated hydrazides into peptide sequences for nabumetone delivery from nanofiber gels.
Area of Science:
- Biomaterials science
- Drug delivery systems
- Organic chemistry
Background:
- Peptide amphiphiles are versatile biomaterials.
- Controlled drug release is crucial for therapeutic efficacy.
- Degradable linkers are needed for responsive drug delivery.
Purpose of the Study:
- To investigate hydrolytically-labile hydrazones as degradable tethers.
- To enable the release of the drug nabumetone from nanofiber gels.
- To achieve precise placement of hydrazides within peptide sequences.
Main Methods:
- Synthesis of a novel tri-Boc-hydrazido adipic acid.
- On-resin incorporation of the hydrazide into a lysine residue.
- Formation of peptide amphiphile nanofibers.
- Study of drug release kinetics.
Main Results:
- Successfully synthesized and incorporated the novel hydrazide compound.
- Demonstrated precise placement of the hydrazide linker in peptide amphiphiles.
- Established hydrazones as effective degradable tethers for drug release.
- Nabumetone release from nanofiber gels was achieved.
Conclusions:
- Hydrolytically-labile hydrazones are viable degradable linkers in peptide amphiphiles.
- This strategy allows for controlled release of nabumetone.
- Precise control over linker placement enhances drug delivery system design.
More Related Videos
Related Concept Videos
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:28Amides to Carboxylic Acids: Hydrolysis
Amides can undergo either acid-catalyzed hydrolysis or base-promoted hydrolysis through a typical nucleophilic acyl substitution. Each hydrolysis requires severe conditions.
Acid-catalyzed hydrolysis:
Hydrolysis of amides under acidic conditions yields carboxylic acids. Since the reaction occurs slowly, hydrolysis requires the conditions of heat.
The mechanism begins with the protonation of the carbonyl oxygen by the acid catalyst. The protonation makes the amide carbonyl carbon more...
Acid-catalyzed hydrolysis:
Hydrolysis of amides under acidic conditions yields carboxylic acids. Since the reaction occurs slowly, hydrolysis requires the conditions of heat.
The mechanism begins with the protonation of the carbonyl oxygen by the acid catalyst. The protonation makes the amide carbonyl carbon more...